24161/34347US=84-A / Biol/Mol
Wilkinson DS, Barton MC. Transformig growth factor-B in developing and advanced cancers: tumor suppressors p53 and TGFB converge to regulate the alpha-fetoprotein oncodevelopmental tumor marker. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 309-20. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

P53; SMAD2; SMAD4; SNON; P73; CROMATINA; FIGADO; HEPATOMA


24162/34347US=84-A / Biol/Mol
Wilkinson DS, Barton MC. Transformig growth factor-B in developing and advanced cancers: tumor suppressors p53 and TGFB converge to regulate the alpha-fetoprotein oncodevelopmental tumor marker. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 309-20. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

P53; SMAD2; SMAD4; SNON; P73; CROMATINA; HEPATOMA


24163/34347US=84-A / Biol/Mol
Andarawewa KL, Kirshner J, Mott JD, Barcellos-Hoff MH. Transformig growth factor-B in developing and advanced cancers: TGFB: roles in DNA damage responses. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 321-33. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

TGFB; DNA DANO; RADIACAO IONIZANTE


24164/34347US=84-A / Biol/Mol
Hjelmeland AB, Rich JN. Transformig growth factor-B in developing and advanced cancers: the rationale for and effects of tergeting TGF-B for glioma therapy. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 335-51. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

GLIOBLASTOMA; FORKHEAD; P15; P21; PAI-1; PETN; VEGF; SB-431542; SD-208


24165/34347US=84-A / Biol/Mol
Bommireddy R, Doetschman T. Transformig growth factor-B in developing and advanced cancers: tumor suppressor functions of TGFB1 in T cells. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 353-66. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

FOXP3; SMAD; TGF-B1; TREG CELULAS; TUMORES; CALCIO; AUTOIMUNIDADE; CAMUNDONGOS KNOCKOUT; CELULAS T


24166/34347US=84-A / Biol/Mol
Saika S. Transformig growth factor-B in developing and advanced cancers: therapeutic effects of adenovirus medated gene transfer of TGF-B signal antagonists on undesirable epithelial-mesenchymal transition and neovascularization. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 367-81. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

TRANSICAO EPITELIAL-MESENQUIMAL; NEOVASCULARIZACAO; CICATRIZACAO DE FERIDAS; FACTOR DE CRESCIMENTO TRANSFORMANTE B; TRANSDUCAO DE SINAL; TERAPIA GENETICA


24167/34347US=84-A / Biol/Mol
Bollard CM, Rooney CM. Transformig growth factor-B in developing and advanced cancers: role of in tumor protection and antitumor immunity. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 383-400. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

TGF-B; CTL; TGF-B RECEPTORES; TGFBRI; TGFBRII; TGFBRIII; IMUNOTERAPIA; CANCER; FATOR TRANSFORMADOR DE CRESCIMENTO - B; LINFOCITO T CITOTOXICO


24168/34347US=84-A / Biol/Mol
Yee KO, Lawler J. Transformig growth factor-B in developing and advanced cancers: regulation of angiogenesis an tumor growth by thrombospondin-1. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 401-15. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

FATOR TRANSFORMADOR DE CRESCIMENTO - B; TROMBOSPONDINA-1; ANGIOGENESE; CANCER; PLASMINOGENIO; GLIOMA; CANCER DE MAMA; MODELO DO RATO; CELULAS ENDOTELIAIS


24169/34347US=84-A / Biol/Mol
Micke P, Moustakas A, Ohshima M, Kappert K. Transformig growth factor-B in developing and advanced cancers: cancer-associated fibroblasts and the role of TGF-B. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 417-41. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

ASSOCIADAS CANCER FIBROBLASTOS; ESTROMA; ASSOCIADAS CANCER FIBROBLASTOS; TUMOR DO ESTROMA INTERACCAO; MIOFIBROBLASTOS; TERAPIA-ALVO; TGFB-1; MICROARRAY; EXPRESSAO DO GENE; CANCER


24170/34347US=84-A / Biol/Mol
Lee C, Shah A, Liu VC, Park II, Wong LY, Huang X, Huang L, Zhou VW, Medler T, Kundu SD, Zhang Q, Smith ND. Transformig growth factor-B in developing and advanced cancers: adoptive transfer of tumor reactive TGF-B insensitive CD8 T cellss for cancer therapy. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 443-61. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

TUMOR DERIVADO DE TGF-B; VIGILANCIA IMUNE; TGF-B; TGF-B INSENSIVEIS CD8 + CELULAS-T; A TRANSFERENCIA ADOPTIVA DE CELULAS CD8 + CELULAS-T; ERRADICACAO DO TUMOR


24171/34347US=84-A / Biol/Mol
Ammanamanchi S, Brattain MG. Transformig growth factor-B in developing and advanced cancers: DNA methylation and histone deacetylation inhibitors as potential therapeutic agents for the reconstitution of TGF-B signaling in breast cancer. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 463-74. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

METILACAO DO DNA; DECITABINA; DESACETILACAO DAS HISTONAS; RII; TGF-B RECEPTOR TIPO II; SP FAMILIA DE GENES; TRICOSTATINA A


24172/34347US=84-A / Biol/Mol
Rowley DR. Transformig growth factor-B in developing and advanced cancers: reactive stroma and evolution of tumors: integration of transforming growth factor-B, connective tissue growth factor, and fibroblast growth factor-2 activities. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 475-505. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

FATOR TRANSFORMADOR DE CRESCIMENTO-B; FATOR DE CRESCIMENTO DO TECIDO CONJUNTIVO; FIBROBLASTOS MIOFIBROBLASTOS DO FACTOR DE CRESCIMENTO; REATIVA ESTROMA


24173/34347US=84-A / Biol/Mol
Pardali E, Liu Z, Scharpfenecker M, Dijke P. Transformig growth factor-B in developing and advanced cancers: TGF-B signaling and vascular morphogenesis. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 507-21. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

TGF-B; HHT; ANGIOGENESE; ENDOGLINA; HHT; TRANSDUCAO DE SINAL


24174/34347US=84-A / Biol/Mol
Korc M. Transformig growth factor-B in developing and advanced cancers: Aberrant growth factor-B signaling in human pancreatic cancer: translational implications. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 523-35. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

SMAD7; TGF-BS; AUTODRINE; ANGIOGENESE; CANCER DE PANCREAS; ALVOS TERAPEUTICOS


24175/34347US=84-A / Biol/Mol
Dennler S, Mawviel A, Verrecchia F. Transformig growth factor-B in developing and advanced cancers: TGF-B and stromal influences over local tumor invasion. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 537-51. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

SMAD; TGF-B; ECM REMODELACAO; MIOFIBROBLASTOS; DESMOPLASIA


24176/34347US=84-A / Biol/Mol
McCartney-Francis NL, Wahl SM. Transformig growth factor-B in developing and advanced cancers: TGF-B at the crossroads between inflammation, suppression and cancer. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 553-70. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

TUMORIGENESE; TREG; SUPRESSAO; TGF-B; LINFOCITOS T; MACROFAGOS


24177/34347US=84-A / Biol/Mol
Datta PK, Mann JR. Development of inhibitors of transforming growth factor-B signaling for therapy: transforming growth factor-B (TGF-B) signaling inhibitors in cancer therapy. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 573-87. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

TGF-B; PEQUENA MOLECULA INIBIDORES; TRANSDUCAO DE SINAL; SUPRESSOR DE TUMOR; PROMOTOR DE TUMOR; BIOMARCADOR; TERAPIA DO CANCER


24178/34347US=84-A / Biol/Mol
Boerma M, Wang J, Corbley MJ, Hauer-Jensen M. Development of inhibitors of transforming growth factor-B signaling for therapy: targeting TGF-B as a strategy to ameliorate intestinal side effects of radiation therapy. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 589-608. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

FATOR TRANSFORMADOR DE CRESCIMENTO-B; COLAGENO; FIBROSE; RADIOTERAPIA; LESOES DE RADIACAO; RECEPTORES DE FACTOR DE CRESCIMENTO TRANSFORMANTE-B; MATRIZ EXTRACELULAR


24179/34347US=84-A / Biol/Mol
Reiss M. Development of inhibitors of transforming growth factor-B signaling for therapy: targetin transforming growth factor-B in metastasis: in vitro and in vivo mechanisms. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 609-34. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

FATOR TRANSFORMADOR DE CRESCIMENTO - B; ANGIOGENESE; CANCER; MOTILIDADE; RESPOSTA IMUNE; INVASAO; METASTASE; TGF-B DO TIPO I; INIBIDOR DA QUINASE DO RECEPTOR; CRESCIMENTO TUMORAL


24180/34347US=84-A / Biol/Mol
Schlingensiepen KH, Jachimczak P, Fischer-Blass B, Fischer D, Specht H, schmaus S, Schlingensiepen R. Development of inhibitors of transforming growth factor-B signaling for therapy: targeted downregulation of TGF-B2 with AP 12009 in tumor therapy. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 635-51. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

OLIGODEOXINUCLEOTIDOS ANTISENSE; CANCER; GLIOMA MALIGNO; TGF-B; USO TERAPEUTICO


Primeira | Anterior | Próxima | Última